rescribing is an essential role in general practice but it is also, at times, a high risk activity. GP Associates-in-Training (GP AiTs) have been highlighted as needing further support to reduce the risk of prescribing errors. This article highlights some common prescribing errors to help GP AiTs to review their prescribing and develop prescribing habits to avoid errors. The general practice workforce is changing and there are more pharmacists working in general practice. This article describes the role of clinical pharmacists in prescribing safety and in supporting GP AiTs.
Are prescribing errors an issue for GP AiTs?
Prescribing errors in both primary and secondary care have the potential to cause significant morbidity and mortality. The GMC's PRACtICe study identified prescribing errors in around one in twenty prescriptions in primary care (Avery et al., 2012) . The study highlighted that, as a group, GP AiTs may benefit from help to reduce their prescribing errors: Based on discussions we have had with GP AiTs, many report a lack of confidence in their role as prescribers and admit to finding the transition from hospital based prescribing to community based prescribing a significant challenge.
All prescribers develop prescribing habits that may reduce or increase the risk of prescribing error. Reflecting on these habits can result in changes that reduce the risk of prescribing error in the long term. A core role for a pharmacist is the identification and prevention of prescribing errors. When a pharmacist is based within a GP practice they are ideally placed to focus on prescribing safety.
Clinical pharmacists in a GP practice
Pharmacists have been working in general practice for a few years in a variety of ways including being directly employed by local NHS organisations such as Clinical Commissioning Groups or directly by GPs.
Many pharmacists are now qualified as independent prescribers.
The NHS Five Year Forward View (NHS England, 2014) acknowledged the increasing pressure in primary care, proposed a sustainable strategy for the NHS and suggested a 'far greater use of pharmacists'. The General Practice Forward View (NHS England, 2016) followed on from this and acknowledged the need to expand the workforce in general practice to meet the increasing demands; it included the incorporation of clinical pharmacists into the practice teams, highlighting that pharmacists 'remain one of the most underutilised professional resources in the system and we must bring their considerable skills in to play more fully'.
The NHS Clinical Pharmacists in General Practice programme has allowed an increasing number of clinical pharmacists to develop new roles within general practice and has supported pharmacists in obtaining an independent prescribing qualification if necessary. The Next
Steps on the Five Year Forward View (NHS England, 2017) continues the commitment to increase the use of pharmacists in general practice to free up GP time and 'ensure efficient use of medicines'.
Historically, the pharmacist's role in GP practice focussed almost entirely on managing prescribing costs and implementing local guidelines, but it has now developed to use the pharmacist's skills in a more clinically orientated, patient-centred role with a key focus on medicines optimisation and prescribing safety. The support for the practicebased pharmacist outlined in the documents above will ensure that the role continues to develop.
Pharmacists supporting prescribing safety with GP AiTs
There are many examples in GP practice of practice-based pharmacists providing support and training to GP AiTs, either during the induction process or as on-going support during their training. One example is a pilot study in the East Midlands (the 100 prescription study); an educational intervention which involved a clinical pharmacist retrospectively reviewing 100 prescription items issued by each GP AiT and then providing feedback. From this we have created ten 'Top tips' that we believe can help support GP AiTs in undertaking a similar review of their prescribing activity. Where there is a clinical pharmacist available in practice, it may be possible to obtain their support in the review.
Top tips for GP AiTs to consider when reviewing prescribing 
Right guidance
Local guidelines and formularies are easy to refer to; they suggest products and dosages specific to the locality and are usually readily Particular consideration should be given to the local antimicrobial guidelines and the local asthma and chronic obstructive pulmonary disease (COPD) guidelines. Antimicrobial guidelines can change relatively frequently and will be specific to the local area with regards to product choice, dosage and course length, as they will reflect local antimicrobial sensitivities. Following local antimicrobial guidelines is important to ensure effective antimicrobial stewardship as outlined in NICE guidance (NICE, 2015a) . Asthma and COPD guidelines will not only reflect national guidance, but also include the locally preferred product choices and corresponding dosages for each stage in treatment.
Examples of errors include:
. Stepping up to Clenil Õ 200 (two doses twice a day) from salbutamol alone in asthma (local guidelines recommend Clenil Õ 100, two doses twice a day)
. Clenil Õ started first line for a patient with suspected COPD
. Prescribing doxycycline and amoxicillin together to treat an exacerbation of COPD. Local guidelines recommend one or the other, but not both together
. Prescribing a 14-day course of ciprofloxacin for acute prostatitis when the local guidelines recommend 28 days
Right dose
There are numerous reasons why an incorrect dosage might be pre- 
Right formulation and strength
Different formulations can change the potency of the medication and there may be more strength options available than realised. Selecting the right formulation and strength of a medication can be further complicated by the introduction of new products to the market.
When prescribing electronically, the selection lists can be confusing and contain unfamiliar products which may result in the incorrect formulation or strength being unknowingly selected. Nationally, there have been incidents (sometimes fatal) due to formulations of high-dose opioid liquids being selected instead of the lower strength e.g. morphine 100 mg in 5 ml solution prescribed instead of morphine 10 mg in 5 ml solution.
Examples of errors include: . Hydrocortisone butyrate 0.1% cream is a potent steroid and was prescribed when standard hydrocortisone cream was intended . Diclofenac 3% gel prescribed for topical pain relief. This strength is licenced for actinic keratosis rather than as a topical antiinflammatory
Right combination
Consideration should be given to other medication that has been recently prescribed (in primary or secondary care) or purchased to avoid patients taking two similar medications at the same time.
The prescribing of brands and branded generics has increased, so extra care is needed to ensure a brand is not prescribed as well as a generic. . Diclofenac tablets prescribed to a patient with a cardiac history
. Ibuprofen gel recommended to be applied to impetigo on the face. Ibuprofen gel should not be used on broken skin
Right directions
Patients frequently do not remember instructions given verbally in a consultation (Kessels, 2003) . Having clear directions on a prescription helps to ensure that medication is used correctly and treatment is optimised. This is particularly important in patients who may have more than one carer or who are prescribed multiple medications.
The directions on a prescription will be added to the product label during the dispensing process. The pharmacy will also transfer the same information to the medication administration charts used in care homes.
Examples of errors include: . Glaucoma drops prescribed to a care home patient without the treatment eye stated . Prescribing morphine sulphate solution 'when required' without stating a frequency or a maximum dosage
. The directions 'Take as directed' for colecalciferol 20 000 unit capsules. There is potential for overdose with high strength vitamin D and a clear dosage should always be added to the medication . Tramadol 50-mg capsules prescribed with the directions 'take one or two as needed' with no indication as to the frequency of dosage or the maximum number of capsules that may be taken in a day
Right review of medication
When a patient requests an item that has been previously prescribed, or an annual medication review is undertaken, the suitability of all medication for continued prescribing should be assessed. Starting with whether there is still a valid clinical indication for the medication the prescriber should also assess whether the medication is an appropriate treatment choice for the indication (bearing in mind any changes in guidelines, other current medication and co-morbidities of the patient). The current dosage should be re-assessed. Although the dose prescribed initially may have been correct, a patient factor could have changed which would require a change to the dosage e.g. change to renal function, weight, or age. It is important to also consider any omissions to therapy e.g. gastroprotection with a nonsteroidal anti-inflammatory drug in an older patient and whether the patient is purchasing or obtaining medication other than from the practice e.g. from the hospital or pharmacy. With the move towards encouraging patients to self-care for minor ailments and conditions, it is even more important to assess what medication is being obtained from other sources than the practice.
Examples of errors include: . Prescribing a further supply of hormone replacement therapy to a 60-year-old patient, whose last medication review was over a year ago, without documenting a discussion regarding risks or considering stopping treatment
. A medication review coded in a patient prescribed aspirin alone post-stroke. National (Royal College of Physicians, 2016) and local guidelines would suggest clopidogrel instead of aspirin alone or aspirin and dipyridamole in combination
. Medication review in a patient with cardiac risk who had never been prescribed a statin and had no documented reason as to why it was not prescribed. A review of the clinical notes showed this had been identified a few years previously by a nurse as something that should be discussed at the next appointment with a GP, but there was no documentation to say that this had occurred
. Clotrimazole 1% cream prescribed with the directions that it should be used in the groin area when the consultation notes state that the rash was under the breasts. The cream was issued as a repeat supply of a previously issued acute prescription but the directions had not been updated
Adherence to medication
Adherence to long-term medication is known to be a problem and is estimated at 30-50%. Assessing adherence is an important part of medicines optimisation (NICE, 2015b) . A medication that is prescribed or even issued regularly cannot be presumed to be taken correctly, to maximal effect and without side effects. Clinicians should endeavour to check how a medication is being taken by the patient and the issue history on the clinical system can help to trigger and support these discussions. The NICE Medicines Optimisation Guidance recommends the use of patient decision aids to assist with shared decision making around prescribing. NHS patient decision aids are available as applications to download to mobile devices or at http://patient.info/decision-aids Examples of errors include: . Patient collecting Clenil Õ regularly but not collecting separate longacting beta agonist inhaler. A medication review had been coded recently but non-adherence had not been addressed
. Asthma inhalers for a child being issued at a higher than expected frequency (inhaled corticosteroid and salbutamol). The parent requested further supply due to running out. Further supply was issued without further questioning as to the child's asthma control . Fluoxetine being collected intermittently at a frequency where daily dosing would not be possible and a medication review coded without discussing antidepressant usage
Right documentation
The clinical record should document the necessary clinical information and checks to support prescribing. This is important even if the indication can be deduced from the item prescribed.
Examples of errors include: . Strong opioids prescribed for the first time during a consultation with no entry in the records indicating the reason for the prescription . Combined oral contraceptive prescribed without recording information on smoking status, weight etc.
. Potent topical steroid started without a clinical indication
. Diazepam prescribed for the first time to a patient who was seen with an interpreter present. The reason for prescribing was not in the consultation notes
The prescribing of some medications should trigger consideration of a second medication to be given concurrently e.g. the prescribing of a non-steroidal anti-inflammatory drug to a patient over 65 years in age would require consideration of gastroprotection. If the item is considered but not required, or declined by the patient, then this should be documented so that other clinicians who access the record are also aware so that it can inform their decisions. An example of this type of error is the prescribing of a strong opioid without documented consideration of co-prescribing a laxative.
Right prescribing experience
GP AiTs should work with GP trainers to ensure that adequate prescribing experience is gained in all the areas that will be needed post qualification. In the 100 prescription study, five categories of medication accounted for almost 50% of prescribing, with almost two-thirds of prescribing being for new acute items. This pattern of prescribing would seem to be different than national prescribing figures for GPs, with a lower propensity for the GP AiTs to be prescribing medication for long-term conditions (Prescribing and Medicines Team Health and Social Care Information Centre, 2016) . If on reviewing their own prescribing, a GP AiT were to find similar results, they may wish to consider how they could expand their prescribing experience within primary care. GP trainers who reflected on these results in relation to their own GP AiTs provided the following quotes:
. I guess one of the things that it revealed to me, which didn't come as a surprise, was the fact that most of his prescribing is in acute prescribing, but I think that's generally the case for our registrars . . .
. I think one of the real things here is the fact that the registrars see patients presenting for acute problems on the day, and I might consider again how I might get the appropriate case mix, because I think it's a reflection of the fact that they're not seeing the same patient case-mix as I am . . .
. When a lot of (his/her) patients who are started on what would be long-term medication . . . that really confirmed the fact that (he/ she) wasn't very good at putting (medicines) on repeats . . .
Summary
Prescribing in general practice is a complicated and integral part of the role of a GP. It is therefore important to ensure GP AiTs feel confident in prescribing and develop good prescribing habits during their training so that there is a durable reduction in the risk of prescribing errors in the long term.
There are many examples of clinical pharmacists working with GP practices to provide training support and facilitate safer prescribing.
There are plans to evaluate the impact of the Clinical Pharmacists in General Practice Programme.
It is hoped that GP AiTs and GP trainers can use the information provided in this article to review their own prescribing and tailor future training. However, when considering safer prescribing, the Top tips provided here should be considered alongside other available prescribing guides and online learning resources available (see Box 1).
KEY POINTS
. Developing good practice prescribing skills as a GP AiT could lead to life-long habits that will defend against prescribing error
. Pharmacists can work effectively as part of the practice team to enhance prescribing safety and support GP AiTs
. Analysing a sample of prescriptions is a useful educational tool for prescribers to review and improve their prescribing habits
. Prescribing guidelines and formularies should be readily accessible and up to date . Adherence to medication should always be assessed when changing or reviewing medication
